NEW YORK, Jan. 26, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the
filing of a class action lawsuit on behalf of purchasers of Agile Therapeutics, Inc. securities (NASDAQ:AGRX) from March 9, 2016
through January 3, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Agile Therapeutics investors
under the federal securities laws.
To join the Agile Therapeutics class action, go to http://rosenlegal.com/cases-1022.html or
call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class
action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY
COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF
YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants issued materially false and misleading
statements to investors and/or failed to disclose that: (1) the Twirla contraceptive patch had an efficacy rating that fell below
peer group standards; (2) over half of patients in its “Secure” Phase 3 Study discontinued the study early; (3) the Twirla patch
therefore allegedly had a slight chance of FDA approval; and (4) as a result, defendants’ positive statements about Agile
Therapeutics’ business, operations, and prospects, were false and misleading and/or lacked a reasonable basis. When the true
details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court
no later than March 7, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the
litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1022.html or
to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law
Firm toll free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter:
https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions
and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com kchan@rosenlegal.com www.rosenlegal.com
